Your browser doesn't support javascript.
loading
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors.
Dekhtiarenko, Iryna; Ratts, Robert B; Blatnik, Renata; Lee, Lian N; Fischer, Sonja; Borkner, Lisa; Oduro, Jennifer D; Marandu, Thomas F; Hoppe, Stephanie; Ruzsics, Zsolt; Sonnemann, Julia K; Mansouri, Mandana; Meyer, Christine; Lemmermann, Niels A W; Holtappels, Rafaela; Arens, Ramon; Klenerman, Paul; Früh, Klaus; Reddehase, Matthias J; Riemer, Angelika B; Cicin-Sain, Luka.
Afiliação
  • Dekhtiarenko I; Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Ratts RB; TomegaVax Inc., Portland, Oregon, United States of America.
  • Blatnik R; Immunotherapy and prevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lee LN; Molecular Vaccine Design, German Center for Infection Research (DZIF), Heidelberg, Germany.
  • Fischer S; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Borkner L; Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Oduro JD; Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Marandu TF; Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Hoppe S; Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Ruzsics Z; Dar es Salaam University College of Education, Dar es Salaam, Tanzania.
  • Sonnemann JK; Immunotherapy and prevention, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mansouri M; Molecular Vaccine Design, German Center for Infection Research (DZIF), Heidelberg, Germany.
  • Meyer C; Institute for Virology, University Medical Center Freiburg, Freiburg, Germany.
  • Lemmermann NA; Department of Vaccinology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
  • Holtappels R; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Arens R; TomegaVax Inc., Portland, Oregon, United States of America.
  • Klenerman P; Institute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Früh K; Institute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Reddehase MJ; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.
  • Riemer AB; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Cicin-Sain L; TomegaVax Inc., Portland, Oregon, United States of America.
PLoS Pathog ; 12(12): e1006072, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27977791
ABSTRACT
Cytomegalovirus (CMV) elicits long-term T-cell immunity of unparalleled strength, which has allowed the development of highly protective CMV-based vaccine vectors. Counterintuitively, experimental vaccines encoding a single MHC-I restricted epitope offered better immune protection than those expressing entire proteins, including the same epitope. To clarify this conundrum, we generated recombinant murine CMVs (MCMVs) encoding well-characterized MHC-I epitopes at different positions within viral genes and observed strong immune responses and protection against viruses and tumor growth when the epitopes were expressed at the protein C-terminus. We used the M45-encoded conventional epitope HGIRNASFI to dissect this phenomenon at the molecular level. A recombinant MCMV expressing HGIRNASFI on the C-terminus of M45, in contrast to wild-type MCMV, enabled peptide processing by the constitutive proteasome, direct antigen presentation, and an inflation of antigen-specific effector memory cells. Consequently, our results indicate that constitutive proteasome processing of antigenic epitopes in latently infected cells is required for robust inflationary responses. This insight allows utilizing the epitope positioning in the design of CMV-based vectors as a novel strategy for enhancing their efficacy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Epitopos Imunodominantes / Infecções por Herpesviridae / Linfócitos T CD8-Positivos / Antígenos Virais Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Virais / Epitopos Imunodominantes / Infecções por Herpesviridae / Linfócitos T CD8-Positivos / Antígenos Virais Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha